Pharmacology Update: Emergency and Controller Medications for Treatment of Asthma-Reference-Cited by-同舟云学术

Pharmacology Update: Emergency and Controller Medications for Treatment of Asthma

Published:2021-08-08 Issue:1 Volume:37 Page:31-35
ISSN:1942-602X
Container-title:NASN School Nurse
language:en
Short-container-title:NASN School Nurse

Author:

Nanda Anil¹,Russell Anne F.²^ORCID,Bingemann Theresa A.³^ORCID

Affiliation:

1. Allergist/Immunologist, Associate Clinical Professor of Medicine, Division of Allergy and Immunology, University of Texas Southwestern Medical Center, Dallas, TX, Asthma and Allergy Center, Lewisville and Flower Mound, TX

2. Nursing Faculty, Spring Arbor University, Spring Arbor, MI

3. Allergist/Immunologist, Associate Professor of Pediatrics and Medicine, University of Rochester, Rochester, NY

Abstract

Asthma is the most common noncommunicable chronic childhood disease, affecting more than 5 million children in the United States. Asthma is the leading cause of school absenteeism. Treatments for asthma are divided into fast-acting medications that are used to relieve symptoms and slower acting (controller) medications that prevent symptoms. Albuterol is the most common fast acting medication for asthma, and it exists in multiple forms, including metered-dose inhaler and nebulized therapy. The use of spacers and holding chambers can further improve medication deposition in the airway. The cornerstone controller therapy for asthma is inhaled corticosteroid. Other medications for asthma include long-acting beta agonists, long-acting antimuscarinics, and antileukotrienes. The newest agents for controller asthma therapies are biologics.

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1942602X211036933

Reference14 articles.

1. American Academy of Asthma Allergy and Immunology & University of Wisconsin–Madison, Department of Medicine. (2016). SAMPRO™ toolkit. https://hipxchange.org/SAMPRO

2. Benton G., Thomas R. C., Nickerson B. G., McQuitty J. C., Okikawa J. (1989). Experience with a metered-dose inhaler with a spacer in the pediatric emergency department. American Journal of Diseases of Children, 143(6), 678-681. https://doi.org/10.1001/archpedi.1989.02150180056020

3. Centers for Disease Control and Prevention. (2019). Most recent national asthma data. https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm

4. Centers for Disease Control and Prevention. (2020). Common asthma triggers. https://www.cdc.gov/asthma/triggers.html#:~:text=Sinus%20infections%2C%20allergies%2C%20pollen%2C,also%20trigger%20an%20asthma%20attack

5. Cloutier M. M., Baptist A. P., Blake K. V., Brooks E. G., Bryant-Stephens T., DiMango E., Dixon A. E., Elward K. S., Hartert T., Krishnan J. A., Lemanske R. F., Ouellette D. R., Pace W. D., Schatz M., Skolnik N. S., Stout J. W., Teach S. J., Umscheid C. A., Walsh C. G. (2020). 2020 Focused updates to the asthma management guidelines: A report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. Journal of Allergy and Clinical Immunology, 146(6), 1217-1270. https://doi.org/10.1016/j.jaci.2020.10.003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Composition, Skin Pharmacokinetics, and Pharmacological Effects of the Sanfu Herbal Patch;Natural Product Communications;2024-08

2. Place of nebulizer therapy in the treatment of bronchial asthma in children;Meditsinskiy sovet = Medical Council;2022-02-27